Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors

被引：0
|
作者：
Huang, Xiu [1 ]
Russell, Meaghan K. [1 ]
Pantazi, Angeliki [2 ]
Lvova, Maria [1 ]
Vuzman, Dana [1 ]
Lyle, Stephen [3 ]
Tse, Julie Y. [4 ]
机构：
[1] KEW Inc, Cambridge, MA USA
[2] KEW Inc, Lethbridge, AB, Canada
[3] Univ Massachusetts, Worcester, MA 01605 USA
[4] KEW Inc, Tufts Med Ctr, Boston, MA USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1950
引用
收藏
页码：701 / 701
页数：1
相关论文
共 50 条
  • [1] Characterization of Biomarkers to Immune Checkpoint Inhibitor Therapy in Solid Tumors
    Huang, Xiu
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lvova, Maria
    Vuzman, Dana
    Lyle, Stephen
    Tse, Julie Y.
    LABORATORY INVESTIGATION, 2018, 98 : 701 - 701
  • [2] Characterization of biomarkers to immune checkpoint blockade therapy across solid tumors.
    Russell, Meaghan
    Huang, Xiu
    Vuzman, Dana
    Lvova, Maria
    Pantazi, Angeliki
    Lyle, Stephen
    Julie, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [3] Biomarkers for immune checkpoint inhibitors in solid tumors
    Kapoor, Vidit
    Kelly, William James
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 126 - 136
  • [4] Biomarkers for immune checkpoint inhibitors in solid tumors
    Vidit Kapoor
    William James Kelly
    Clinical and Translational Oncology, 2023, 25 : 126 - 136
  • [5] Tissue biomarkers of immune checkpoint inhibitor therapy
    Davoudi, Fatemeh
    Moradi, Afshin
    Sadeghirad, Habib
    Kulasinghe, Arutha
    IMMUNOLOGY AND CELL BIOLOGY, 2024, 102 (03): : 179 - 193
  • [6] Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
    Gubbi, Sriram
    Vijayvergia, Namrata
    Yu, Jian Q.
    Klubo-Gwiezdzinska, Joanna
    Koch, Christian A.
    HORMONE AND METABOLIC RESEARCH, 2022, 54 (12) : 795 - 812
  • [7] Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors
    Kennedy, Laura C.
    Bhatia, Shailender
    Thompson, John A.
    Grivas, Petros
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (06): : 750 - 757
  • [8] Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy
    Failing, Jarrett J.
    Dudek, Olivia A.
    Acevedo, Julian A. Marin
    Chirila, Razvan M.
    Dong, Haidong
    Markovic, Svetomir N.
    Dronca, Roxana S.
    FUTURE ONCOLOGY, 2019, 15 (22) : 2645 - 2656
  • [9] Molecular imaging biomarkers for immune checkpoint inhibitor therapy
    van de Donk, Pim P.
    de Ruijter, Laura Kist
    Lub-de Hooge, Marjolijn N.
    Brouwers, Adrienne H.
    van der Wekken, Anthonie J.
    Oosting, Sjoukje F.
    Fehrmann, Rudolf S. N.
    de Groot, Derk Jan A.
    de Vries, Elisabeth G. E.
    THERANOSTICS, 2020, 10 (04): : 1708 - 1718
  • [10] Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
    Arora, Sanjeevani
    Velichinskii, Rodion
    Lesh, Randy W.
    Ali, Usman
    Kubiak, Michal
    Bansal, Pranshu
    Borghaei, Hossein
    Edelman, Martin J.
    Boumber, Yanis
    ADVANCES IN THERAPY, 2019, 36 (10) : 2638 - 2678
12345